Literature DB >> 6154645

Studies on the mechanism of action of cyclosporin A.

D Wiesinger, J F Borel.   

Abstract

The mechanism of cyclosporin A (CS-A), a compound known to act selectively on the immunocompetent lymphocyte, was investigated in a series of in vitro studies. CS-A, provided it was added simultaneously with mitogen, inhibited the incorporation of tritiated uridine and thymidine into mouse spleen cells and human peripheral blood lymphocytes. Addition of CS-A 48 h after onset of culture did not affect cell division, indicating that it acted at an early stage of lymphocyte stimulation, exerted no inhibitory effect on lymphoblasts and did not possess anti-mitotic activity. It was further shown that CS-A was not lymphotoxic and that its effect was reversible, because suppressed spleen cells recovered their proliferative capacity after a 24 h elution period. Inhibition of PFC in the Mishell-Dutton assay provides evidence of an anti-T helper cell action of CS-A.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6154645     DOI: 10.1016/S0171-2985(80)80078-7

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  29 in total

1.  Cyclosporin A inhibits phorbol ester-induced activation of superoxide production in resident mouse peritoneal macrophages.

Authors:  M D Chiara; F Bedoya; F Sobrino
Journal:  Biochem J       Date:  1989-11-15       Impact factor: 3.857

2.  Conversion of liver allograft recipients from cyclosporine to FK 506-based immunosuppression: benefits and pitfalls.

Authors:  J J Fung; S Todo; A Tzakis; A Demetris; A Jain; K Abu-Elmaged; M Alessiani; T E Starzl
Journal:  Transplant Proc       Date:  1991-02       Impact factor: 1.066

3.  T-cell-independent macrophage activation in mice induced with rRNA from Listeria monocytogenes and dimethyldioctadecylammonium bromide.

Authors:  J F van den Bosch; I Y Kanis; A C Antonissen; W A Buurman; C P van Boven
Journal:  Infect Immun       Date:  1986-09       Impact factor: 3.441

4.  Cyclosporin A prevents induction of the interleukin 2 receptor gene in cultured murine thymocytes.

Authors:  J F Gauchat; E W Khandjian; R Weil
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

5.  Antimalarial activity of cyclosporin A.

Authors:  K Thommen-Scott
Journal:  Agents Actions       Date:  1981-12

6.  Interference of cyclosporin with lymphocyte activation: blockage of the mitogen-induced increases of lysosomal and mitochondrial activities.

Authors:  M Koponen; A Grieder; F Loor
Journal:  Immunology       Date:  1984-09       Impact factor: 7.397

7.  Ribonuclease-sensitive ribosomal vaccines.

Authors:  R Gonggrijp; A C Antonissen; J F van den Bosch; C P van Boven
Journal:  Antonie Van Leeuwenhoek       Date:  1984       Impact factor: 2.271

8.  Contribution to knowledge of the biosynthesis of cyclosporin A.

Authors:  H Kobel; H R Loosli; R Voges
Journal:  Experientia       Date:  1983-08-15

9.  Cyclosporin receptor on mouse lymphocytes.

Authors:  B Ryffel; P Donatsch; U Götz; M Tschopp
Journal:  Immunology       Date:  1980-12       Impact factor: 7.397

10.  Selective induction of immunological tolerance in antiviral T killer cells of inbred mice after treatment with cyclosporin A.

Authors:  D Armerding
Journal:  Infect Immun       Date:  1981-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.